Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company's core product, ReOxy, is a CE-marked commercial medical device for individualized intermittent hypoxia-hyperoxia treatment (IHHT®) with evidence-based efficacy for cardiovascular, cerebrovascular, and metabolic disease rehabilitation. The approach is clinically validated and used within the EU in both research and clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ai Mediq.